about
Linezolid-induced optic neuropathy: a mitochondrial disorder?Endophytic fungi: a reservoir of antibacterialsFrequency and antibiotic susceptibility of gram-positive bacteria in Makkah hospitalsSynthesis and antimicrobial evaluation of nitazoxanide-based analogues: identification of selective and broad spectrum activityIsolation and identification of a Paenibacillus polymyxa strain that coproduces a novel lantibiotic and polymyxin.In vitro and in vivo activities of antibiotic PM181104.Staphylococcus aureus host cell invasion and virulence in sepsis is facilitated by the multiple repeats within FnBPAReal-World Experience with Oritavancin Therapy in Invasive Gram-Positive Infections.Evaluation of the medicinal use of clay minerals as antibacterial agents.Bacillus anthracis edema toxin inhibits Staphylococcus aureus enterotoxin B effects in vitro: a potential protein therapeutic?CEM-101 activity against Gram-positive organisms.μHall chip for sensitive detection of bacteriaRapid emergence of resistance to linezolid during linezolid therapy of an Enterococcus faecium infection.Prospects for aminoacyl-tRNA synthetase inhibitors as new antimicrobial agents.The Staphyloccous aureus Eap protein activates expression of proinflammatory cytokines.Broad-spectrum in vitro antibacterial activities of clay minerals against antibiotic-susceptible and antibiotic-resistant bacterial pathogensBurden of methicillin-resistant Staphylococcus aureus: focus on clinical and economic outcomes.Daptomycin and tigecycline: a review of clinical efficacy in the antimicrobial era.Update on the appropriate use of linezolid in clinical practiceAntimicrobial resistance pattern of Gram-positive bacteria during three consecutive years at the nephrology ward of a tertiary referral hospital in Shiraz, Southwest Iran.Antibacterial activity of 2-(2',4'-dibromophenoxy)-4,6-dibromophenol from Dysidea granulosa.Efficacy of NZ2114, a novel plectasin-derived cationic antimicrobial peptide antibiotic, in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.Linezolid: a promising option in the treatment of Gram-positives.Ubiquitous detection of gram-positive bacteria with bioorthogonal magnetofluorescent nanoparticles.Telavancin penetration into human epithelial lining fluid determined by population pharmacokinetic modeling and Monte Carlo simulation.IL-17A plays an important role in protection induced by vaccination with fibronectin-binding domain of fibronectin-binding protein A against Staphylococcus aureus infection.Dispersion of the Vancomycin Resistance Genes vanA and vanC of Enterococcus Isolated from Nile Tilapia on Retail Sale: A Public Health Hazard.Chalcone Attenuates Staphylococcus aureus Virulence by Targeting Sortase A and Alpha-Hemolysin.Structures of S. aureus thymidylate kinase reveal an atypical active site configuration and an intermediate conformational state upon substrate binding.Case report of a successful treatment of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia and MRSA/vancomycin-resistant Enterococcus faecium cholecystitis by daptomycin.Use of peptide-major histocompatibility complex tetramer technology to study interactions between Staphylococcus aureus proteins and human cells.Effect of biosurfactants on Pseudomonas aeruginosa and Staphylococcus aureus biofilms in a BioFlux channel.Rapid identification of clinically relevant Enterococcus species by fluorescence in situ hybridization.Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized studyAM-7359--a novel oxazolidinone with low resistance potential and potent activity against drug resistant pathogens.Disinfection and healing effects of 222-nm UVC light on methicillin-resistant Staphylococcus aureus infection in mouse wounds.
P2860
Q24678948-EA4AA3D1-3964-42B4-8E7C-DC742FCBF08CQ28083549-EFECAC21-D591-4552-BA90-331B5A3A403FQ28392343-67AE344F-E763-431C-9B29-D3383423B77CQ30427797-68A5A9B9-35EF-4DD9-85E7-BC61CFE7D560Q31071398-AF5C5D75-2816-47F4-BCB5-53FFBCE7310DQ31126282-20868E35-6D13-4CA3-B160-DECE7C41B9B4Q33619097-1D9E4A2A-4FC2-472A-BB9E-A9445978B2A2Q33732555-5409BF3F-160D-431C-BE94-3D1B8B02F58CQ33995558-76BFF0B5-F0DD-4403-BD51-85F04C1A3E6EQ34033516-548A39A5-1746-4B6A-AB50-2ACF14C562F9Q34100146-2AE55CEB-112B-46C8-A6CE-E7962EEEEF0CQ35122043-4A6730C5-3818-4B4B-8D88-260D171C7830Q35215431-1D0FF21A-6FAA-4A43-8D36-7E643BFA2E1FQ36320180-CAACDA37-71F4-4F2F-8BC5-36BBA51B1471Q36594046-FEC1AB10-FA24-48DE-BEAE-00E2E8DAD34AQ36700223-E792611D-1CCC-470A-A7F4-39025FA1AED9Q36861645-182515C6-0C4F-4CB5-8791-1A37D1E86E87Q36967265-2EFF75A1-5852-4CD4-AF07-0DFD40EB1B96Q37116859-33F8243C-9305-4AC0-970A-4DFDF5BA3E4CQ37374748-36520E3D-C1AB-4A61-8FA1-7669979B2255Q37389954-E2B96F5D-0206-4B24-A816-84C77062D1DCQ38726627-13049B69-8DCB-45B5-8C63-79124109B10FQ39044932-5FCF3AA0-4023-4A30-8F5E-3799179DF63CQ39326133-615136B7-8D5D-433E-BBD4-204F0B8C3F83Q39686295-252192B9-17F2-4D56-B5C4-40A1D5532E53Q40264299-6346F4B0-C450-480B-8607-5D5EDE43860DQ40543990-5B00AE43-ACA6-4C40-9EBE-79B92FC7F75DQ41400482-5CAEF235-2CE0-4C43-944E-A16E2D0F0334Q41840329-15DE8A46-A567-4BEF-AAD6-395067783A40Q41960102-8DE69F18-670A-45CB-805C-E35C9CE3D318Q42265411-B2D7FB0A-6BB5-45D1-BA40-29D5F3427068Q42577490-A8A8305F-6CB1-49C2-96EB-0375E25AA63BQ42637833-0A8636FB-355F-4D72-9890-22104EA3AB64Q43694841-0AF987A4-C5BE-4F70-9D09-6905BFC58F20Q44267462-00F6DF67-9180-469A-9AB6-EE71EE69259FQ47442305-5CD50E4F-E9E5-42F6-B87B-14B39920094B
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Current and emerging serious Gram-positive infections.
@ast
Current and emerging serious Gram-positive infections.
@en
Current and emerging serious Gram-positive infections.
@nl
type
label
Current and emerging serious Gram-positive infections.
@ast
Current and emerging serious Gram-positive infections.
@en
Current and emerging serious Gram-positive infections.
@nl
prefLabel
Current and emerging serious Gram-positive infections.
@ast
Current and emerging serious Gram-positive infections.
@en
Current and emerging serious Gram-positive infections.
@nl
P1476
Current and emerging serious Gram-positive infections.
@en
P2093
Menichetti F
P356
10.1111/J.1469-0691.2005.01138.X
P478
11 Suppl 3
P577
2005-05-01T00:00:00Z